Fentanyl Transdermal Patch and Vemurafenib: Interaction Details

Brand names
Fentanyl Transdermal Patch
DuragesicAbstralSubsys +3 more
Vemurafenib
Zelboraf
Same medicines, other forms
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page

A close look at the Fentanyl Transdermal Patch and Vemurafenib interaction:

Share

Share this interaction

Fentanyl Transdermal Patch

Brand names
  • Duragesic
  • Abstral
  • Subsys
  • Ionsys
  • Actiq
  • Fentora

What Happens When You Take Fentanyl Transdermal Patch With Vemurafenib

What can happen when they are taken together (rated Major)

Reduced exposure of fentaNYL, reduced of fentaNYL and/or onset of withdrawal symptoms

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

When fentaNYL is taken together with a , plasma fentaNYL concentrations can fall. This may lessen the efficacy of fentaNYL, or it may trigger opioid withdrawal syndrome in a patient who has become physically dependent on fentaNYL.

If the combination cannot be avoided, the patient should be monitored for signs of opioid withdrawal, and an increase in the fentaNYL dosage may be considered until stable drug effects are reached. Once the CYP3A4 inducer is stopped, plasma fentaNYL concentrations will rise, which may enhance or prolong both the therapeutic and the adverse effects of fentaNYL, including the risk of serious . When a CYP3A4 inducer is discontinued, a reduction in the fentaNYL dosage should be considered, and patients should be evaluated at frequent intervals for signs of respiratory depression and .1432

The Fentanyl Transdermal Patch and Vemurafenib Interaction, Explained

Vemurafenib (Zelboraf) can speed up the way your liver breaks down fentanyl, the pain medicine in the Duragesic patch. That means less fentanyl may stay in your body, so your patch might not control your pain as well. If your body is used to fentanyl, you could even feel withdrawal symptoms, like restlessness, sweating, or aches.

There is another side to this. If vemurafenib is stopped later, fentanyl levels can rise again, which can cause extra sleepiness or slowed breathing. Please don't change your patch on your own. Tell your pharmacist or doctor about both medicines so they can adjust your dose and keep a close eye on you.

Mechanism: Vemurafenib induces , increasing and intestinal of fentanyl (a CYP3A4 ; fentanyl is active itself, not a that needs activation). Expected effect is reduced fentanyl exposure (/) with loss of analgesia and possible withdrawal in dependent patients.

  • Evidence: probable; onset unspecified; severity major.
  • Co-use: monitor for withdrawal and inadequate analgesia; consider increasing the fentanyl dose until effects are stable.
  • If the is stopped: fentanyl levels rise, with risk of prolonged effects and serious . Consider dose reduction and frequent evaluation for and respiratory depression.

See the 6 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Fentanyl Transdermal Patch and Vemurafenib Interact

The likely mechanism

of -mediated of fentaNYL

In short: Vemurafenib speeds up CYP3A4, an enzyme that breaks down fentanyl, so fentanyl can be cleared faster.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When One Drug Lowers Another’s Level”, one chapter of our one-minute explainer. See how it works 

How to Manage the Fentanyl Transdermal Patch and Vemurafenib Interaction

Keep using both medicines as prescribed unless your prescriber tells you otherwise. Your care team may adjust and individualize your fentanyl dose and may monitor you more closely.

  • Tell your pharmacist or prescriber if your pain is less controlled or you notice withdrawal symptoms such as restlessness, sweating, or aches.
  • If vemurafenib is ever stopped, your fentanyl dose may need to be lowered, and your team will check you often for sleepiness or slowed breathing.
  • Seek urgent help for severe drowsiness or trouble breathing.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Fentanyl Transdermal Patch or Vemurafenib need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

1 report from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1

    A 64-year-old man who was taking rifAMPin, a strong ,5 could not achieve adequate pain control with optimized doses of transdermal fentaNYL and rescue pain medications until he was changed to morphine. The patient had colon cancer and was taking rifAMPin 450 mg/day as part of an antitubercular regimen for pulmonary tuberculosis.

    Pain control was not reached even though the fentaNYL dose was raised from 0.6 mg/day to 2.5 mg/day and rescue medication was given. When fentaNYL was replaced with sustained-release oral morphine at a dose analgesically equivalent to fentaNYL (180 mg/day), pain control was achieved.

    Afterward, however, the patient developed a disturbance in consciousness, which was attributed to a morphine side effect. According to the Naranjo probability scale, rifAMPin was a possible cause of the lack of response to fentaNYL.6

Fentanyl Transdermal Patch and Vemurafenib: Common Questions

How serious is the Fentanyl Transdermal Patch and Vemurafenib interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Fentanyl Transdermal Patch and Vemurafenib interaction managed?

Keep using both medicines as prescribed unless your prescriber tells you otherwise. Your care team may adjust and individualize your fentanyl dose and may monitor you more closely. Tell your pharmacist or prescriber if your pain is less controlled or you notice withdrawal symptoms such as restlessness, sweating, or aches. If vemurafenib is ever stopped, your fentanyl dose may need to be lowered, a… Management is individual — always follow your own care team's guidance.

Does taking Fentanyl Transdermal Patch and Vemurafenib at different times of day help?

No. Taking them at different times of day does not prevent this one. Vemurafenib speeds up , an enzyme that breaks down fentanyl, so fentanyl can be cleared faster. That change lasts while vemurafenib is being taken and can continue for a while after the last dose.

Your pharmacist or prescriber can tell you how they will manage it.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Ask About the Fentanyl Transdermal Patch and Vemurafenib Interaction

Ask in your own words about taking Fentanyl Transdermal Patch and Vemurafenib together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (6)

  1. Product Information: DURAGESIC(R) transdermal system, fentanyl transdermal system. Janssen Pharmaceuticals Inc (per manufacturer), Titusville, NJ, 2018. DailyMed
  2. Product Information: ACTIQ(R) oral transmucosal lozenge, fentanyl citrate oral transmucosal lozenge. Teva Pharmaceuticals USA, Inc. (per FDA), Parsippany, NJ, 2023. DailyMed
  3. Product Information: Fentanyl citrate intravenous, intramuscular injection, fentanyl citrate intravenous, intramuscular injection. Hospira Inc (per FDA), Lake Forest, IL, 2023. DailyMed
  4. Product Information: FENTORA(R) buccal tablets, fentanyl citrate buccal tablets. Teva Pharmaceuticals USA Inc (per FDA), Parsippany, NJ, 2023.
  5. Certara Drug Interactions Solutions: Certara Drug Interaction Database (DIDB(R)). Princeton, NJ: Certara, May 2024.
  6. Morii H, Chiba M, Konishi H, et al: Failure of pain control using transdermal fentanyl during rifampicin treatment. J Pain Symptom Manage 2007; 33(1):5-6. PubMed
Was this write-up helpful?

Other Serious Interactions of Fentanyl Transdermal Patch and Vemurafenib

Also serious with Fentanyl Transdermal Patch

Also serious with Vemurafenib

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Vemurafenib

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven. This interaction.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.